Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_assertion type Assertion NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_head.
- NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_assertion description "[From 1990 through 2000, urologic measures of BPH were assessed biennially from lower urinary tract symptom severity, peak flow rates, prostate volume, serum prostate specific antigen (PSA) level, acute urinary retention, and treatment for BPH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_provenance.
- NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_assertion evidence source_evidence_literature NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_provenance.
- NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_assertion SIO_000772 16302261 NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_provenance.
- NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_assertion wasDerivedFrom gad-20130706 NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_provenance.
- NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_assertion wasGeneratedBy ECO_0000203 NP55494.RAZ_W6sz0Lbc9VdRmO9V-YSzpaXFTb6zeZC57Yoxu3BDc130_provenance.